Recently, some studies evaluated cerebrospinal fluid (CSF) orexin levels in Alzheimer’s disease (AD), finding a high level of orexin A that correlates with AD progression, sleep fragmentation and neuropsychiatric symptoms [4]. The gene discussed is HCRT; the disease is early-onset autosomal dominant Alzheimer disease.